Dose and duration of fenfluramine-phentermine therapy impacts the risk of significant valvular heart disease

Norman E. Lepor, Stacey B. Gross, William L. Daley, Bruce A. Samuels, Michael J. Rizzo, Sean P. Luko, Ann Hickey, Neil A. Buchbinder, Tasneem Z. Naqvi

Research output: Contribution to journal › Article › peer-review

30 Scopus citations

Fingerprint

Dive into the research topics of 'Dose and duration of fenfluramine-phentermine therapy impacts the risk of significant valvular heart disease'. Together they form a unique fingerprint.